|
Catalog Number KIV2200 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bone Fracture(s) (1870); Pain (1994)
|
Event Date 06/09/2015 |
Event Type
Injury
|
Event Description
|
It was reported that on (b)(6) 2015, a kiva vcf procedure was performed and the patient had two levels (l1 and l2) treated successfully.Products were discarded by the hospital post kiva procedure as the devices performed as expected.Upon a follow-up visit on (b)(6) 2015, the patient reported lumbar pain and subsequent mri revealed additional collapse at l1, with posterior fragmentation and minor retropulsion into the spinal canal.The treating physician reported that the original treatment was without issue, although there was a very large cleft and that it extended to the posterior wall.The physician felt that the event was likely due to a vertical fracture line that existed prior to the original procedure, and that it was difficult to see on imaging.On (b)(6) 2015, the physician treated the level with vertebroplasty procedure and the patient is reportedly doing well.No additional information was provided.
|
|
Manufacturer Narrative
|
Evaluation summary: the device was not returned as there was no reported device malfunction.A review of the lot history record confirmed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, the fractured vertebral body reported in this incident appears to be related to patient/procedural conditions.The patient effect of 'pain or lack of pain relief' is listed in the kiva vcf treatment system instructions for use ((b)(4)) as a known possible complication associated with kiva procedures.In this case, the reported lumbar pain and subsequent mri revealed additional collapse at l1, was likely a result of a vertical fracture line that existed prior to the original procedure, and that it was difficult to see in imaging, as indicated by the treating physician.In this case, although a definitive cause for the reported patient effects cannot be determined, there is no indication of a product deficiency.Based on the information reviewed, there is no indication of a product deficiency; therefore, no corrective action is necessary at this time.Benvenue will continue to monitor these types of incidents and take the necessary steps to correct any further findings.
|
|
Search Alerts/Recalls
|
|
|